Tristel

LSE:TSTL UK Medical Instruments & Supplies
Market Cap
$2.29 Million
GBX18.81 Billion GBX
Market Cap Rank
#43672 Global
#741 in UK
Share Price
GBX392.50
Change (1 day)
+0.64%
52-Week Range
GBX270.00 - GBX440.00
All Time High
GBX617.87
About

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more

Tristel (TSTL) - Total Assets

Latest total assets as of December 2025: GBX45.43 Million GBX

Based on the latest financial reports, Tristel (TSTL) holds total assets worth GBX45.43 Million GBX as of December 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Tristel - Total Assets Trend (2003–2025)

This chart illustrates how Tristel’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Tristel - Asset Composition Analysis

Current Asset Composition (June 2025)

Tristel's total assets of GBX45.43 Million consist of 57.7% current assets and 42.3% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 19.1%
Accounts Receivable GBX7.06 Million 15.6%
Inventory GBX4.64 Million 10.2%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX5.02 Million 11.1%
Goodwill GBX4.97 Million 11.0%

Asset Composition Trend (2003–2025)

This chart illustrates how Tristel's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Tristel's current assets represent 57.7% of total assets in 2025, an increase from 48.9% in 2003.
  • Cash Position: Cash and equivalents constituted 19.1% of total assets in 2025, up from -0.5% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 43.0% in 2003.
  • Asset Diversification: The largest asset category is accounts receivable at 15.6% of total assets.

Tristel Competitors by Total Assets

Key competitors of Tristel based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Tristel - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.77 - 1.02

Strong asset utilization - Tristel generates 1.02x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 2.55% - 16.99%

Excellent ROA - For every $100 in assets, Tristel generates $ 14.65 in net profit.

Tristel - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.13 3.98 3.23
Quick Ratio 3.45 3.19 2.48
Cash Ratio 0.00 0.00 0.00
Working Capital GBX20.00 Million GBX 17.36 Million GBX 11.87 Million

Tristel - Advanced Valuation Insights

This section examines the relationship between Tristel's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.63
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 2.8%
Total Assets GBX45.33 Million
Market Capitalization $22.16K USD

Valuation Analysis

Below Book Valuation: The market values Tristel's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Tristel's assets grew by 2.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Tristel (2003–2025)

The table below shows the annual total assets of Tristel from 2003 to 2025.

Year Total Assets Change
2025-06-30 GBX45.33 Million +2.78%
2024-06-30 GBX44.11 Million +6.63%
2023-06-30 GBX41.37 Million +6.78%
2022-06-30 GBX38.74 Million -2.98%
2021-06-30 GBX39.93 Million -2.45%
2020-06-30 GBX40.93 Million +43.66%
2019-06-30 GBX28.49 Million +26.41%
2018-06-30 GBX22.54 Million +12.07%
2017-06-30 GBX20.11 Million +7.05%
2016-06-30 GBX18.79 Million +10.43%
2015-06-30 GBX17.01 Million +12.81%
2014-06-30 GBX15.08 Million +18.30%
2013-06-30 GBX12.75 Million -13.53%
2012-06-30 GBX14.74 Million +5.96%
2011-06-30 GBX13.91 Million +16.48%
2010-06-30 GBX11.95 Million +81.70%
2009-06-30 GBX6.57 Million +14.23%
2008-06-30 GBX5.75 Million +23.08%
2007-06-30 GBX4.68 Million +37.33%
2006-06-30 GBX3.40 Million +17.62%
2005-06-30 GBX2.90 Million +232.00%
2004-04-30 GBX872.00K 0.00%
2003-06-30 GBX872.00K --